Oncodesign Precision Medicine SA Sustainability Reports
Oncodesign Precision Medicine S.A. is a biopharmaceutical company that discovers and develops precision therapies and artificial intelligence-driven diagnostic platforms to target therapeutic resistance and metastasis in advanced cancers and other unmet clinical needs.
Sector: Professional & technical services
Country: France
Exchange: Euronext Paris
LEI: 969500ZDX1IY47LDL876
FIGI: BBG018N4GD38
2 reports from 2023 to 2025
